Gilead officer Dickinson proposes $469K share sale
The notice also lists two earlier 3,000-share sales, on August 17 and September 15, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Gilead Sciences, Inc. officer Andrew Dickinson gave notice of a proposed sale of 3,000 common shares, with an aggregate market value of $468,660, through Morgan Stanley Smith Barney LLC; the notice lists October 15, 2026, as the approximate sale date and Nasdaq as the exchange. It identifies 3,000 performance shares acquired from the issuer on January 31, 2024. It also lists two sales during the prior three months: 3,000 shares on September 15, 2026, for $435,870 and 3,000 shares on August 17, 2026, for $415,080.
Key Figures
Key Terms
Rule 144 regulatory
Aggregate market value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.